Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BEAM |
---|---|---|
09:32 ET | 10618 | 24.26 |
09:34 ET | 5372 | 24.11 |
09:36 ET | 1489 | 24.01 |
09:38 ET | 2495 | 23.995 |
09:39 ET | 949 | 24.015 |
09:41 ET | 2792 | 24.035 |
09:43 ET | 1300 | 23.91 |
09:45 ET | 3300 | 23.9268 |
09:48 ET | 2100 | 23.885 |
09:50 ET | 5598 | 23.97 |
09:52 ET | 600 | 23.9786 |
09:54 ET | 7135 | 23.96 |
09:56 ET | 1701 | 23.91 |
09:57 ET | 2210 | 23.82 |
09:59 ET | 3003 | 23.86 |
10:01 ET | 4739 | 24.05 |
10:03 ET | 1343 | 23.96 |
10:06 ET | 1959 | 23.9 |
10:08 ET | 1690 | 23.73 |
10:10 ET | 1024 | 23.65 |
10:12 ET | 12329 | 23.55 |
10:14 ET | 4351 | 23.54 |
10:15 ET | 2064 | 23.62 |
10:17 ET | 1735 | 23.502 |
10:19 ET | 3856 | 23.44 |
10:21 ET | 1606 | 23.475 |
10:24 ET | 1221 | 23.44 |
10:26 ET | 2744 | 23.49 |
10:28 ET | 1120 | 23.395 |
10:30 ET | 4307 | 23.41 |
10:32 ET | 2719 | 23.46 |
10:33 ET | 2697 | 23.51 |
10:35 ET | 710 | 23.535 |
10:37 ET | 912 | 23.53 |
10:39 ET | 533 | 23.525 |
10:42 ET | 3193 | 23.44 |
10:44 ET | 2300 | 23.505 |
10:46 ET | 1080 | 23.5 |
10:48 ET | 340 | 23.525 |
10:50 ET | 2830 | 23.49 |
10:51 ET | 1347 | 23.465 |
10:53 ET | 2591 | 23.475 |
10:55 ET | 2182 | 23.395 |
10:57 ET | 1550 | 23.415 |
11:00 ET | 1668 | 23.395 |
11:02 ET | 1173 | 23.38 |
11:04 ET | 7625 | 23.24 |
11:06 ET | 4039 | 23.195 |
11:08 ET | 10159 | 23.24 |
11:09 ET | 2010 | 23.18 |
11:11 ET | 100 | 23.15 |
11:13 ET | 3966 | 23.18 |
11:15 ET | 1530 | 23.2 |
11:18 ET | 4585 | 23.155 |
11:20 ET | 1798 | 23.19 |
11:22 ET | 500 | 23.16 |
11:24 ET | 2609 | 23.21 |
11:26 ET | 2206 | 23.16 |
11:27 ET | 1818 | 23.22 |
11:29 ET | 1300 | 23.245 |
11:31 ET | 1061 | 23.245 |
11:33 ET | 983 | 23.245 |
11:36 ET | 1005 | 23.29 |
11:38 ET | 1172 | 23.3 |
11:40 ET | 471 | 23.32 |
11:42 ET | 1400 | 23.29 |
11:44 ET | 1256 | 23.4 |
11:45 ET | 2701 | 23.4 |
11:47 ET | 3800 | 23.33 |
11:49 ET | 200 | 23.31 |
11:51 ET | 3166 | 23.325 |
11:54 ET | 750 | 23.335 |
11:56 ET | 2698 | 23.33 |
11:58 ET | 1112 | 23.3 |
12:00 ET | 1145 | 23.33 |
12:02 ET | 2516 | 23.29 |
12:03 ET | 1414 | 23.32 |
12:05 ET | 626 | 23.4 |
12:07 ET | 705 | 23.36 |
12:09 ET | 1675 | 23.32 |
12:12 ET | 1111 | 23.341 |
12:14 ET | 1275 | 23.355 |
12:16 ET | 900 | 23.36 |
12:18 ET | 100 | 23.37 |
12:20 ET | 600 | 23.3855 |
12:21 ET | 800 | 23.34 |
12:23 ET | 1000 | 23.32 |
12:25 ET | 2785 | 23.33 |
12:27 ET | 3479 | 23.32 |
12:30 ET | 1561 | 23.3 |
12:32 ET | 1662 | 23.335 |
12:34 ET | 2315 | 23.24 |
12:36 ET | 1567 | 23.325 |
12:38 ET | 1610 | 23.37 |
12:39 ET | 212 | 23.32 |
12:41 ET | 4387 | 23.33 |
12:43 ET | 2378 | 23.295 |
12:45 ET | 1602 | 23.295 |
12:48 ET | 4393 | 23.34 |
12:50 ET | 2185 | 23.31 |
12:52 ET | 2281 | 23.34 |
12:54 ET | 400 | 23.36 |
12:56 ET | 946 | 23.41 |
12:57 ET | 600 | 23.36 |
12:59 ET | 674 | 23.42 |
01:01 ET | 852 | 23.38 |
01:03 ET | 3096 | 23.2802 |
01:06 ET | 1218 | 23.33 |
01:08 ET | 2667 | 23.275 |
01:10 ET | 5254 | 23.27 |
01:12 ET | 1663 | 23.26 |
01:14 ET | 7081 | 23.27 |
01:15 ET | 6423 | 23.24 |
01:17 ET | 3679 | 23.25 |
01:19 ET | 2224 | 23.245 |
01:21 ET | 1126 | 23.28 |
01:24 ET | 2800 | 23.2799 |
01:26 ET | 7733 | 23.27 |
01:28 ET | 2779 | 23.24 |
01:30 ET | 1384 | 23.27 |
01:32 ET | 1107 | 23.3 |
01:33 ET | 870 | 23.35 |
01:35 ET | 343 | 23.37 |
01:37 ET | 200 | 23.33 |
01:39 ET | 695 | 23.32 |
01:42 ET | 1455 | 23.3 |
01:44 ET | 400 | 23.31 |
01:46 ET | 2610 | 23.315 |
01:48 ET | 400 | 23.36 |
01:50 ET | 955 | 23.29 |
01:51 ET | 900 | 23.323634 |
01:53 ET | 300 | 23.295 |
01:55 ET | 1066 | 23.31 |
01:57 ET | 1115 | 23.37 |
02:00 ET | 1428 | 23.42 |
02:02 ET | 437 | 23.42 |
02:04 ET | 1114 | 23.48 |
02:06 ET | 622 | 23.44 |
02:08 ET | 1119 | 23.48 |
02:09 ET | 300 | 23.5 |
02:11 ET | 400 | 23.53 |
02:13 ET | 300 | 23.56 |
02:15 ET | 1025 | 23.53 |
02:18 ET | 950 | 23.57 |
02:20 ET | 1052 | 23.51 |
02:22 ET | 603 | 23.53 |
02:24 ET | 324 | 23.53 |
02:26 ET | 500 | 23.54 |
02:27 ET | 300 | 23.605 |
02:29 ET | 451 | 23.63 |
02:31 ET | 1001 | 23.66 |
02:33 ET | 975 | 23.655 |
02:36 ET | 6505 | 23.724 |
02:38 ET | 976 | 23.75 |
02:40 ET | 4254 | 23.725 |
02:42 ET | 4029 | 23.665 |
02:44 ET | 1509 | 23.635 |
02:45 ET | 400 | 23.62 |
02:47 ET | 400 | 23.6532 |
02:49 ET | 1207 | 23.6625 |
02:51 ET | 760 | 23.67 |
02:54 ET | 300 | 23.675 |
02:56 ET | 404 | 23.675 |
02:58 ET | 5102 | 23.72 |
03:00 ET | 613 | 23.73 |
03:02 ET | 1722 | 23.7241 |
03:03 ET | 1585 | 23.73 |
03:05 ET | 1679 | 23.75 |
03:07 ET | 1829 | 23.75 |
03:09 ET | 264 | 23.77 |
03:12 ET | 856 | 23.7923 |
03:14 ET | 1157 | 23.765 |
03:16 ET | 1017 | 23.7 |
03:18 ET | 2709 | 23.725 |
03:20 ET | 1600 | 23.75 |
03:21 ET | 1077 | 23.745 |
03:23 ET | 2478 | 23.745 |
03:25 ET | 1958 | 23.705 |
03:27 ET | 1153 | 23.715 |
03:30 ET | 1840 | 23.67 |
03:32 ET | 306 | 23.53 |
03:34 ET | 1526 | 23.51 |
03:36 ET | 1223 | 23.48 |
03:38 ET | 2280 | 23.35 |
03:39 ET | 2813 | 23.355 |
03:41 ET | 1921 | 23.405 |
03:43 ET | 3160 | 23.38 |
03:45 ET | 3079 | 23.32 |
03:48 ET | 5151 | 23.46 |
03:50 ET | 2150 | 23.511 |
03:52 ET | 5912 | 23.48 |
03:54 ET | 2640 | 23.415 |
03:56 ET | 5830 | 23.42 |
03:57 ET | 19859 | 23.42 |
03:59 ET | 200753 | 23.41 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Beam Therapeutics Inc | 2.0B | -13.3x | --- |
Galapagos NV | 1.9B | 53.5x | --- |
Genmab A/S | 16.1B | 19.3x | +22.71% |
Catalyst Pharmaceuticals Inc | 2.4B | 37.9x | --- |
Maravai LifeSciences Holdings Inc | 2.1B | -8.1x | --- |
Veracyte Inc | 2.6B | -44.5x | --- |
Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. The Company's suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it is also advancing programs in other genetic diseases, as well as immunology/oncology. Its primary programs include BEAM-101, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-302, BEAM-301 and BEAM-201. BEAM-101 is a patient-specific, autologous hematopoietic stem cell (HSC), investigational therapy. ESCAPE is a potentially non-genotoxic approach to HSC transplantation. BEAM-302 is a liver-targeting lipid nanoparticle formulation of base editing reagents. BEAM-201 is an anti-CD7 CAR-T product candidate.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.0B |
---|---|
Revenue (TTM) | $352.6M |
Shares Outstanding | 82.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.85 |
EPS | $-1.76 |
Book Value | $12.02 |
P/E Ratio | -13.3x |
Price/Sales (TTM) | 5.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -52.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.